Back

Anti-inflammatory effects of atorvastatin and colchicine combination in patients with acute or chronic coronary syndrome undergoing coronary angiography and/or PCI

28 August 2026 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Emerging pharmacologic strategies in coronary artery disease: anti-inflammatory, antithrombotic, and cardiometabolic approaches Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Theerapol Trijitwatthanakoon

Police General Hospital, Bangkok (Thailand)

5 More presentations in this session

Presentation thumbnail
Assessment of long-term safety of pro-angiogenic growth approaches in cardiovascular disease: A systematic review
Professor D. Bates (Nottingham, GB)
Abstract Slides
Presentation thumbnail
Leukotriene receptor antagonists and lower risk of major adverse cardiovascular events in patients with asthma
Assistant Professor J. Le Van (Montreal, CA)
Abstract Slides
Presentation thumbnail
A pharmacodynamic analysis of genotype-guided P2Y12-inhibitor monotherapy or dual antiplatelet therapy after PCI in patients with chronic coronary syndrome – the POPular STRATEGY study
Miss Q. Van De Pol (Nieuwegein, NL)
Abstract Slides
Presentation thumbnail
Empagliflozin attenuates coronary atherosclerosis by promoting the differentiation of pericoronary adipose-derived stem cells
Mr S. Shi (Nanjing, CN)
Abstract Slides
Presentation thumbnail
Colchicine serum levels in patients with chronic coronary syndrome
Miss J. Jannink (Utrecht, NL)
Abstract Slides

Access the full session

Session thumbnail
Emerging pharmacologic strategies in coronary artery disease: anti-inflammatory, antithrombotic, and cardiometabolic approaches

The Event

Event poster

ESC Congress 2026

28 August 2026 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Effect of colchicine on reducing c-reactive protein levels among patients with acute coronary syndrome: a meta-analysis
27 August 2021
thumbnail
Congress Presentation
High-dose statins are associated with increased aortic valve calcium load in patients with severe stenosis
25 April 2024
thumbnail
Congress Presentation
Real-world use of rosuvastatin 40 mg and ezetimibe 10 mg after ACS: is this combination effective in achieving guideline-recommended LDL-C goals after discharge?
20 March 2026
thumbnail
Congress Presentation
Reduction of perivascular inflammation following long-term statin treatment - a coronary CT follow-up study using Fat Attenuation Index
25 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources